In reply
We thank Dr Geller for his letter regarding our recent article.1 In his letter, Dr Geller suggests that clinicians appropriately reject evidence-based guidelines for LBP because (1) the use of paracetamol poses an unacceptably high risk of adverse events compared with NSAIDs and (2) opioids have some benefit in disease progression.